A chemist, she lent her expertise in drug research to ACT UP, an organization known for its street protests, and helped ...

Deploying lenacapavir will require rethinking who delivers HIV prevention, how it is financed, and what policy infrastructure ...

The International Diabetes Federation (IDF) officially recognized a fifth form of diabetes in 2025, after decades of ...

Florida’s HIV-positive patients will continue to be able to rely on the state for help getting medication for the next few months, thanks to a last-minute scramble from the Florida Legislature that ...

Ms. Szalavitz is a contributing Opinion writer who covers addiction and public policy. See more of our coverage in your search results.Encuentra más de nuestra cobertura en los resultados de búsqueda.

Antiretroviral therapy has decreased the risk of lymphoma in the HIV-positive patient population, yet the incidence is still approximately 70-times greater than the incidence in the noninfected ...

Perhaps, like me, you get more unsolicited news notifications on your phone or computer “than Carter has little pills,” a folksy way of saying way too many. A news notification that caught my heart ...

Heparin-induced thrombocytopenia (HIT) is an immune-mediated platelet disorder caused by antibodies that target complexes of platelet factor 4 (PF4) and heparin. HIT has been characterized as a ...

Mary Fisher speaks at the Republican National Convention on August 19., 1992. During a sweaty night in Houston 33 years ago, on Aug. 19, 1992, I spoke to the Republican National Convention and, via ...

When Drs. David Blatt and David Moore founded the AIDS ward at Illinois Masonic Hospital in Lake View in 1985, they figured they were all but guaranteed to end up in one of the unit’s beds, ...

PF pathogenesis involves alveolar epithelial cell injury, profibrotic mediators, and dysregulated non-coding RNAs, complicating disease management. Current treatments, including pirfenidone and ...

Forbes contributors publish independent expert analyses and insights. Sally Pipes is a scholar and think tank CEO who writes on health care. "The progress that science has made against HIV/AIDS is ...